bpc 157 dosage mg per day bpc-157 dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Dosage: A Complete Guide
Description
AOD 9604 is a modified peptide initially developed as an offshoot in obesity research
Multiple human and animal studies confirm that AOD-9604 has zero impact on fasting glucose, fasting insulin, HbA1c, IGF-1, cortisol, or thyroid hormones
It is not a dietary supplement, medicine, or food product and is not intended for human consumption
For instance, Northern Ireland has reported an increased frequency of such cases
